Freidenrich Center for Translational Research (CTRU) — Palo Alto, California

Freidenrich Center for Translational Research (CTRU) is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.

Freidenrich Center for Translational Research (CTRU) has participated in 2 clinical trials.

Therapeutic areas: Hematologic Malignancies, Solid Tumor, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

• Stanford University Medical Centre
• VA Palo Alto Health Care System, NC-PTSD, Dissemination and Training Division
• Stanford University Hospital and Medical Center
• Stanford University Medical Center CTRU - 800 Welch Road
• Lucile Packard Children's Hospital & Stanford Hospital
• VA Palo Alto - Cardiac Catheterization Laboratory
• Stanford University School of Medicine, Dermatology Department
• Lucile Packard Children's Hospital Stanford
• Palo Alto Veterans Affairs Hospital System
• Stanford University Clinical and Translational Research Unit
• Stanford University VA
• Stanford University School of Medicine Center for Academic Medicine

Sponsor Feasibility Report

Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Freidenrich Center for Translational Research (CTRU)?

Freidenrich Center for Translational Research (CTRU) has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Freidenrich Center for Translational Research (CTRU) conducted?

Freidenrich Center for Translational Research (CTRU) has 2 clinical trials on record. Their work covers Hematologic Malignancies, Solid Tumor, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Is Freidenrich Center for Translational Research (CTRU) accredited by Crixeo Clinical Trials?

Freidenrich Center for Translational Research (CTRU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Freidenrich Center for Translational Research (CTRU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.